Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Superseded

This Document Has Been Replaced By: Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)

December 23, 2011
By United States. Advisory Committee on Immunization Practices. Vaccines Work Group. ...
Series: MMWR. Morbidity and mortality weekly report ; v. 60, no. no. 50, p. 1709-11

English

Details You May Also Like

Details:

Journal Article:

MMWR. Morbidity and mortality weekly report
Corporate Authors:

United States. Advisory Committee on Immunization Practices. Vaccines Work Group. ; Centers for Disease Control and Prevention (U.S.)

United States. Advisory Committee on Immunization Practices. Vaccines Work Group. ; Centers for Disease Control and Prevention (U.S.) Less -
Description:

Hepatitis B virus (HBV) causes acute and chronic infection of the liver leading to substantial morbidity and mortality. In the United States, since 1996, a total of 29 outbreaks of HBV infection in one or multiple long-term-care (LTC) facilities, including nursing homes and assisted-living facilities, were reported to CDC; of these, 25 involved adults with diabetes receiving assisted blood glucose monitoring. These outbreaks prompted the Hepatitis Vaccines Work Group of the Advisory Committee on Immunization Practices (ACIP) to evaluate the risk for HBV infection among all adults with diagnosed diabetes. The Work Group reviewed HBV infection-related morbidity and mortality and the effectiveness of implementing infection prevention and control measures. The strength of scientific evidence regarding protection was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology,* and safety, values, and cost-effectiveness were incorporated into a recommendation using the GRADE system. Based on the Work Group findings, on October 25, 2011, ACIP recommended that all previously unvaccinated adults aged 19 through 59 years with diabetes mellitus (type 1 and type 2) be vaccinated against hepatitis B as soon as possible after a diagnosis of diabetes is made (recommendation category A). Data on the risk for hepatitis B among adults aged ≥60 years are less robust. Therefore, ACIP recommended that unvaccinated adults aged ≥60 years with diabetes may be vaccinated at the discretion of the treating clinician after assessing their risk and the likelihood of an adequate immune response to vaccination (recommendation category B). This report summarizes these recommendations and provides the rationale used by ACIP to inform their decision making.

PMID: 22189894
Content Notes:

Stanton

8/24/2015
Subjects:

[+]

Cost-Benefit Analysis Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Hepatitis B/complications Hepatitis B/mortality Hepatitis B/prevention & Control Hepatitis B Vaccines/administration & Dosage Hepatitis B Vaccines/economics Infection Control/standards Risk
Series:

MMWR. Morbidity and mortality weekly report ; v. 60, no. no. 50, p. 1709-11
Document Type:

Journal Article
Genre:

Practice Guideline
Place as Subject:

United States
Pages in Document:

pages 1709-11
Volume:

60
Issue:

50
Collection(s):

Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:a5d230569ca3e82dbdd4b13dda200074b2d1278862b79ffdd2a2a6ab03f86109
Download URL:

https://stacks.cdc.gov/view/cdc/7471/cdc_7471_DS1.pdf
File Type:

[PDF-3.23 MB]